RPGLIFE vs VALIANTLAB: Stock Comparison

RPG Life Sciences Limited vs Valiant Laboratories Limited

Live data: 22 July 2026, 3:04 PM IST • Source: NSE and company filings

RPG Life Sciences Limited is the larger company by market capitalisation. RPG Life Sciences Limited shows a higher ROE, a higher dividend yield and faster revenue growth, while Valiant Laboratories Limited shows a lower P/E. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of RPG Life Sciences Limited and Valiant Laboratories Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, RPGLIFE is more favourable on 8 of 13 scored metrics and VALIANTLAB on 5These counts are context-free and are not an overall rating.

Key Differences

Market Cap
RPGLIFE is the larger company
₹4,948 Cr vs ₹332 Cr
P/E Ratio
VALIANTLAB has a lower P/E
-101.88x vs 43.37x
P/B Ratio
VALIANTLAB has a lower P/B
1.07x vs 8.25x
EPS
RPGLIFE has higher earnings per share
₹69.65 vs ₹-0.05
Dividend Yield
RPGLIFE has a higher dividend yield
0.75% vs 0%
Revenue Growth (TTM YoY)
RPGLIFE has faster revenue growth
23.6% vs 0%
EPS Growth (TTM YoY)
VALIANTLAB has faster EPS growth
0% vs -74.5%
Qtr Sales Growth
VALIANTLAB has stronger quarterly sales growth
148% vs 23.6%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricRPGLIFEVALIANTLAB
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricRPGLIFEVALIANTLAB
Live Price₹3,001₹81.65
Day Change0.1%2.55%
Volume30,18587,489
52-Week High₹3,082₹100.98
52-Week Low₹1,733₹49.51
Distance from 52W High-2.63%-19.14%

Valuation

MetricRPGLIFEVALIANTLAB
Market Cap₹4,948 Cr₹332 Cr
P/E Ratio43.37x-101.88x
P/B Ratio8.25x1.07x
EPS₹69.65₹-0.05
Book Value₹366.04₹50.08
Dividend Yield0.75%0%

Growth

MetricRPGLIFEVALIANTLAB
Revenue Growth (TTM YoY)23.6%0%
EPS Growth (TTM YoY)-74.5%0%
Qtr Sales Growth23.6%148%
Qtr Profit Growth33.7%457%

Profitability & Leverage

MetricRPGLIFEVALIANTLAB
ROE19.3%-1.05%
ROCE25.7%-0.95%
Net Margin29.25%-1.38%
Operating Margin20.9%1.12%
Debt to Equity0.03x0.14x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricRPGLIFEVALIANTLAB
Promoter Holding72.95%74.94%
FII Holding0.87% 0.13 pp0% 0.2 pp
DII Holding7.45% 0.41 pp0%
Public Holding18.73% 0.28 pp25.06% 0.2 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: RPG Life Sciences Limited and Valiant Laboratories Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.